Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences has raised $24.0M in total funding. The most recent round was Series G. The last funding was announced in April 2023.
Epic Sciences's investors include Venrock, LabCorp, Deerfield, Arsenal Capital Partners, Alexandria Venture Investments.
Epic Sciences is headquartered in La Jolla, United States.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is at the Series G stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epic Sciences — Funding & Investors." VCBacked, April 14, 2023, https://www.vcbacked.co/company/epic-sciences. Accessed October 31, 2026.
VCBacked. (2023). Epic Sciences — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/epic-sciences
{{cite web |title=Epic Sciences — Funding & Investors |url=https://www.vcbacked.co/company/epic-sciences |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated